Qiagen (QGEN) Tops Q4 EPS by 2c, Beats on Revenues; 'Sets FY18 Outlook for Further Growth in Adj. Net Sales & Adj. EPS'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Qiagen NV (QGEN) PT Raised to $37.50 at Evercore ISI
February 1, 2018 1:00 PM ESTEvercore ISI raised its price target on Qiagen NV (NASDAQ: QGEN) to $37.50 (from $35.00) while maintaining an Outperform rating follownig results.
Analyst Ross Muken notes Management is comfortable with meeting mid-term targets without the potential contribution from QIAStat. In addition, QIAStat instrument builds on the... More
Qiagen (QGEN) Agrees to Acquire STAT-Dx
January 31, 2018 4:35 PM ESTQIAGEN N.V. (NYSE: QGEN) announced today it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
The... More
Goldman Sachs Views Lab Stocks as Attractive, Neutral on Diagnostics; LabCorp (LH) Top Pick, Myriad (MYGN) the Bottom
January 29, 2018 12:41 PM ESTLab Corp. (NYSE: LH) shares up over 1%, after Goldman Sachs assumed coverage of the company, also adding LH to the GS Conviction List with a Buy rating and price target of $205. Analyst Patrick Donnelly highlights LH with an "Attractive" coverage view, citing continued market consolidation and strong macro data, fueled by "healthy underlying volume growth" and "meaningful tax benefits."
The note... More
Goldman Sachs Starts Qiagen NV (QGEN) at Buy
January 29, 2018 4:49 AM ESTGoldman Sachs initiates coverage on Qiagen NV (NASDAQ: QGEN) with a Buy rating and a price target of $39.00.
Analyst Patrick Donnelly comments "We see a clear path to 75+bps of margin expansion annually through 2020 and see valuation as attractive, particularly relative to... More
